Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NUVASIVE, INC.

(NUVA)
  Report
Delayed Quote. Delayed Nasdaq - 01/21 04:00:00 pm
57.79 USD   +2.12%
01/12NuVasive Seeks Acquisitions
CI
01/12NUVASIVE INC : Regulation FD Disclosure (form 8-K)
AQ
01/10NUVASIVE : J.P. Morgan 40th Annual Healthcare Conference
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about NUVASIVE, INC.
01/12NuVasive Seeks Acquisitions
CI
01/10NUVASIVE : J.P. Morgan 40th Annual Healthcare Conference
PU
01/05NuVasive Gets US FDA 510(k) Clearance for Expanded Indications of Use for Attrax Putty
MT
01/05NuVasive Receives FDA Clearance for Expanded Indications of Use for Attrax Putty with C..
PR
01/05Nuvasive Receives FDA Clearance for Expanded Indications of Use for Attrax Putty with T..
CI
2021NuVasive to Participate in 40th Annual J.P. Morgan Healthcare Conference
PR
2021Truist Securities Adjusts Price Target on NuVasive to $60 From $75, Maintains Buy Ratin..
MT
2021RBC Initiates NuVasive at Outperform With $60 Price Target, Noting 'Material Backlog, N..
MT
2021NuVasive to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference
PR
2021Globus Medical in Talks About Possible NuVasive Takeover
MT
2021Globus Medical Reportedly Eyes Acquisition of NuVasive
CI
2021NuVasive Shares Halted, Globus Reportedly Makes Early Takeover Approach
MT
2021Morgan Stanley Adjusts NuVasive's Price Target to $62 From $67, Maintains Equalweight R..
MT
2021UBS Adjusts NuVasive PT to $54 From $59, Maintains Sell Rating
MT
2021Needham Cuts NuVasive's Price Target to $64 From $73, Citing Q3 Miss; Buy Rating Kept
MT
2021Credit Suisse 30th Annual Healthcare Conference
PU
2021NuVasive Announces Third Quarter 2021 Financial Results - Form 8-K
PU
2021NuVasive, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sep..
CI
2021Tranche Update on NuVasive, Inc.'s Equity Buyback Plan announced on October 24, 2017.
CI
2021NUVASIVE : Q3 Earnings Snapshot
AQ
2021NuVasive, Inc. Revises Earnings Guidance for the Full-Year 2021
CI
2021NuVasive, Inc. Appoints Amy Belt Raimundo to Serve as a Member of the Compensation Comm..
CI
2021Earnings Flash (NUVA) NUVASIVE Posts Q3 Revenue $270.8M, vs. Street Est of $291.2M
MT
2021Earnings Flash (NUVA) NUVASIVE Posts Q3 EPS $0.32, vs. Street Est of $0.54
MT
2021NuVasive Announces Third Quarter 2021 Financial Results
PR
2021EARNINGS REACTION HISTORY : NUVASIVE INC, 60.0% Follow-Through Indicator, 4.7% Sensitive
MT
2021Q3 2021 NuVasive®, Inc. Earnings Conference Call
PU
2021NuVasive, Inc. announces an Increase in Equity Buyback.
CI
2021NuVasive to Present at Credit Suisse 30th Annual Healthcare Conference
PR
2021Loop Capital Initiates Coverage on NuVasive With Hold Rating, $65 Price Target
MT
2021NuVasive to Sponsor and Participate in Society for Minimally Invasive Spine Surgery Ann..
PR
2021Needham Lowers NuVasive's Price Target to $73 From $80 on Q3 Revenue Update; Buy Rating..
MT
2021NuVasive to Release Cutting-edge Virtual Reality Training for Lateral, Single-position ..
PR
2021NuVasive, Inc. to Release Cutting-edge Virtual Reality Training for Lateral, Single-pos..
CI
2021NUVASIVE : Announces Conference Call and Webcast of Third Quarter 2021 Results
PR
2021NUVASIVE : Launches Latest Porous PEEK Implant for Posterior Spine Surgery
PR
2021NuVasive Launches Latest Porous PEEK Implant for Posterior Spine Surgery
CI
2021NUVASIVE : Announces First Commercial Cases Utilizing the Pulse Platform
PR
2021NuVasive Announces First Commercial Cases Utilizing the Pulse Platform
CI
2021NUVASIVE : Opens East Coast Experience Center in New York Metropolitan Area
PR
2021NuVasive, Inc. Opens East Coast Experience Center in New York Metropolitan Area
CI
2021NUVASIVE : Morgan Stanley 19th Annual Global Healthcare Conference
PU
2021NuVasive, Inc. Simplify Cervical Disc Data Publishes in International Journal of Spine ..
CI
2021NUVASIVE : Announces New Executive Leadership Roles (Form 8-K)
PU
2021NUVASIVE : Names Technology, Commerce Chiefs
MT
2021NUVASIVE : Announces New Executive Leadership Roles
PR
2021NuVasive, Inc. Announces Executive Changes
CI
2021NUVASIVE : to Present at Upcoming Investor Conference
PR
2021Lucas Vitale to Resign as Senior Vice President, Chief Human Resources Officer of NuVas..
CI
2021NUVASIVE : Amy Belt Raimundo to Join NuVasive Board of Directors
PR
2021NuVasive, Inc. Appoints Amy Belt Raimundo to the Board of Directors
CI
2021NUVASIVE : Secures FDA's Clearance for Spine Surgery Platform
MT
2021NuVasive Receives Latest FDA 510(k) Clearance for Pulse Platform and Announces Commerci..
CI
2021NUVASIVE : UBS Adjusts NuVasive's Price Target to $62 From $57; Sell Rating Kept
MT
2021NUVASIVE : Q2 Earnings Snapshot
AQ
2021Nuvasive, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
2021Tranche Update on NuVasive, Inc.'s Equity Buyback Plan announced on October 24, 2017.
CI
2021NUVASIVE : Second Quarter 2021 Supplemental Financials
PU
2021NUVASIVE : Second Quarter 2021 Release
PU
2021NUVASIVE : Earnings Flash (NUVA) NUVASIVE Reports Q2 EPS $0.60, vs. Street Est of $0.46
MT
2021NUVASIVE : Earnings Flash (NUVA) NUVASIVE Posts Q2 Revenue $294.8M, vs. Street Est of $285..
MT
2021NUVASIVE : Announces Second Quarter 2021 Financial Results
PR
2021NuVasive, Inc. Provides Earnings Guidance for the Year 2021
CI
2021NUVASIVE : Q2 2021 NuVasive®, Inc. Earnings Conference Call
PU
2021NUVASIVE : Launches Modulus ALIF 3D-Printed Porous Titanium Implant for Anterior Spine Sur..
PR
2021NuVasive, Inc. Launches Modulus ALIF 3D-Printed Porous Titanium Implant for Anterior Sp..
CI
2021NUVASIVE : Statement on MAGEC, July 15, 2021—US
PU
2021NUVASIVE : Announces Conference Call and Webcast of Second Quarter 2021 Results
PR
2021NUVASIVE : Updated Pulse Platform Receives CE Mark Approval
MT
2021INSIDER TRENDS : Insider Sale at NuVasive Scaling Back 90-Days of Buying
MT
2021INSIDER TRENDS : Insider Disposition Eases Back 90-Day Buy Trend at NuVasive
MT
2021INSIDER TRENDS : Insider at NuVasive Acquires Stock Via Option/Derivative Security Sells P..
MT
2021NUVASIVE : Appoints Daniel J. Wolterman as Independent Board Chair (Form 8-K)
PU
2021NUVASIVE : Appoints Independent Board Chair
MT
2021NUVASIVE : Appoints Daniel J. Wolterman as Independent Board Chair
PR
1  2  3  4  5  6  7  8  9Next
Upcoming event on NUVASIVE, INC.
02/24/22